BRPI0413481A - cascas de lêvedos para o tratamento ou a prevenção da hiperglicemia ou para a estabilização da glicemia - Google Patents

cascas de lêvedos para o tratamento ou a prevenção da hiperglicemia ou para a estabilização da glicemia

Info

Publication number
BRPI0413481A
BRPI0413481A BRPI0413481-8A BRPI0413481A BRPI0413481A BR PI0413481 A BRPI0413481 A BR PI0413481A BR PI0413481 A BRPI0413481 A BR PI0413481A BR PI0413481 A BRPI0413481 A BR PI0413481A
Authority
BR
Brazil
Prior art keywords
stabilization
prevention
treatment
eggshells
hyperglycaemia
Prior art date
Application number
BRPI0413481-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Lucien Lesaffre
Original Assignee
Lesaffre & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lesaffre & Cie filed Critical Lesaffre & Cie
Publication of BRPI0413481A publication Critical patent/BRPI0413481A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BRPI0413481-8A 2003-08-11 2004-08-10 cascas de lêvedos para o tratamento ou a prevenção da hiperglicemia ou para a estabilização da glicemia BRPI0413481A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03018222 2003-08-11
EP03020253 2003-09-08
PCT/EP2004/008933 WO2005021015A1 (fr) 2003-08-11 2004-08-10 Ecorces de levures pour le traitement ou la prevention de l’hyperglycemie ou pour la stabilisation de la glycemie

Publications (1)

Publication Number Publication Date
BRPI0413481A true BRPI0413481A (pt) 2006-10-17

Family

ID=34276722

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413481-8A BRPI0413481A (pt) 2003-08-11 2004-08-10 cascas de lêvedos para o tratamento ou a prevenção da hiperglicemia ou para a estabilização da glicemia

Country Status (17)

Country Link
US (2) US7459159B2 (enExample)
EP (1) EP1663266B1 (enExample)
JP (2) JP4808619B2 (enExample)
KR (1) KR101076209B1 (enExample)
AU (1) AU2004267928B2 (enExample)
BR (1) BRPI0413481A (enExample)
CA (1) CA2534791C (enExample)
DK (1) DK1663266T3 (enExample)
EA (1) EA009677B1 (enExample)
ES (1) ES2405934T3 (enExample)
MA (1) MA28072A1 (enExample)
MX (1) MXPA06001741A (enExample)
NO (1) NO20061138L (enExample)
NZ (1) NZ545594A (enExample)
PL (1) PL1663266T3 (enExample)
PT (1) PT1663266E (enExample)
WO (1) WO2005021015A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006117566A (ja) * 2004-10-20 2006-05-11 Asahi Breweries Ltd 糖代謝改善剤
JP2007195444A (ja) * 2006-01-26 2007-08-09 Asahi Food & Healthcare Ltd ダイエット飲食品
US20100008877A1 (en) * 2006-08-24 2010-01-14 Kirin Holdings Kabushiki Kaisha Composition for improving skin condition
JP5238166B2 (ja) * 2007-02-02 2013-07-17 株式会社ヤクルト本社 インターロイキン１２産生抑制剤
FR2919187B1 (fr) * 2007-07-25 2009-11-27 Lesaffre & Cie Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
FR2949064B1 (fr) * 2009-08-14 2011-10-07 Lesaffre & Cie Nouvelles compositions destinees a la prevention et/ou au traitement du diabete
FR2978967B1 (fr) * 2011-08-09 2020-03-20 Lesaffre Et Compagnie Ecorces de levure enrichies en vitamine d2, compositions les contenant, leur procede de preparation, leurs utilisations et dispositif permettant la mise en oeuvre du procede
MD4216C1 (ro) * 2012-08-15 2013-11-30 Институт Микробиологии И Биотехнологии Академии Наук Молдовы Tulpină de drojdii Saccharomyces cerevisiae - producătoare de manani
JP6932689B2 (ja) * 2016-04-14 2021-09-08 テーブルマーク株式会社 血糖値低下用又はｇｉ値低減用の食品組成物又は組み合わせ
US20190307823A1 (en) * 2016-05-17 2019-10-10 KOHJIN Life Sciences Co., Ltd. Yeast extract having diabetes prevention effect
IT201600069379A1 (it) * 2016-07-04 2018-01-04 Prosol S P A Composizione sostanzialmente costituita da pareti cellulari di lievito e procedimento per la sua preparazione
FI3685681T3 (fi) * 2019-01-23 2024-08-28 Lesaffre & Cie Hiivatuote, ja sitä sisältävä koostumus, käytettäväksi esibioottisena aineena

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5774072A (en) * 1980-10-29 1982-05-10 Yamanouchi Pharmaceut Co Ltd Granule of dietary fiber and its preparation
US4992540A (en) * 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
JPS61167622A (ja) * 1985-01-22 1986-07-29 Asahi Breweries Ltd 糖尿病コントロ−ル剤
US4962094A (en) * 1988-10-28 1990-10-09 Alpha Beta Technology, Inc. Glucan dietary additives
ATE251391T1 (de) * 1993-12-28 2003-10-15 Nestle Sa Cerealien enthaltendes lebensmittel mit einem hohen gehalt an löslichen ballaststoffen
DE4413023A1 (de) * 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Gewinnung eines Faktors mit insulinartiger Wirkung aus Hefeextrakt
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
US5773426A (en) * 1996-06-07 1998-06-30 Masaki Shirota Proteoglucan and antidiabetic drug thereof
WO1998013056A1 (en) * 1996-09-25 1998-04-02 Gracelinc Limited Beta-glucan products and extraction processes from cereals
DE19835767A1 (de) * 1998-08-07 2000-02-17 Kulicke Werner Michael Verfahren zur Gewinnung hochmolekularer biologisch aktiver immunmodulierender Polysaccharide aus Hefe Saccharomyces Cerevisiae
FR2800076B1 (fr) 1999-10-22 2003-11-14 Lesaffre & Cie Mannoproteines solubles
ATE407151T1 (de) * 2000-07-03 2008-09-15 Granate Seed Ltd In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung
CN100391439C (zh) * 2001-04-27 2008-06-04 味之素株式会社 免疫增强剂
FR2825004B1 (fr) * 2001-05-22 2005-02-11 Bio Springer Produit dietetique satiant
WO2002098440A1 (en) * 2001-06-01 2002-12-12 Ajinomoto Co., Inc. Drugs for diabetes
US20030118989A1 (en) * 2001-12-21 2003-06-26 Carsten Rosenow Differential isolation of cellular content for biological assays

Also Published As

Publication number Publication date
US20090022758A1 (en) 2009-01-22
EA200600402A1 (ru) 2006-08-25
JP4808619B2 (ja) 2011-11-02
KR20060037432A (ko) 2006-05-03
NZ545594A (en) 2009-09-25
PL1663266T3 (pl) 2013-07-31
CA2534791A1 (fr) 2005-03-10
EP1663266B1 (fr) 2013-02-20
JP2007501829A (ja) 2007-02-01
NO20061138L (no) 2006-05-10
JP2011178794A (ja) 2011-09-15
CA2534791C (fr) 2014-10-28
AU2004267928A1 (en) 2005-03-10
AU2004267928B2 (en) 2010-10-21
ES2405934T3 (es) 2013-06-04
PT1663266E (pt) 2013-04-30
US7459159B2 (en) 2008-12-02
US20060257422A1 (en) 2006-11-16
EP1663266A1 (fr) 2006-06-07
EA009677B1 (ru) 2008-02-28
KR101076209B1 (ko) 2011-10-24
MA28072A1 (fr) 2006-08-01
DK1663266T3 (da) 2013-05-13
WO2005021015A1 (fr) 2005-03-10
MXPA06001741A (es) 2006-05-12

Similar Documents

Publication Publication Date Title
BR0317747A (pt) Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
BRPI0413481A (pt) cascas de lêvedos para o tratamento ou a prevenção da hiperglicemia ou para a estabilização da glicemia
BRPI0410503B8 (pt) composição tópica e uso da composição
BR0213540A (pt) Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos
EA200501095A1 (ru) Фенилацетамиды и их применение в качестве модуляторов глюкокиназы
BR0316906A (pt) administração do capsaicinoides
MXPA03006771A (es) Anticuerpos modificados y metodos de uso.
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BRPI0414565A (pt) composições farmacêuticas e métodos que compreendem combinações de derivados de 2-alquilideno-19-nor-vitamina d e um bisfosfonato
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
ECSP055739A (es) Anticuerpos de neutralización contra gdf-8, y sus usos
BR9911076A (pt) Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica
BR0116169A (pt) Composto, composição farmacêutica que compreende esse composto, processo para a preparação de uma composição farmacêutica, utilização dos compostos, processo para o tratamento profilático ou terapêutico de diabetes do tipo ii e processo para a preparação do composto.
BRPI0416796A (pt) compostos orgánicos
DE69840909D1 (de) Analoge von kokain
MXPA05012827A (es) Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino.
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
BRPI0415781A (pt) método para o tratamento de diabetes em um paciente e kit farmacêutico
ES2093498T3 (es) Composicion adelgazante.
BRPI9910024B8 (pt) uso de uma mistura de alcoóis de açúcar contendo 6-o-alfa-d-glicopiranosil-d-sorbitol (1,6-gps) e 1-o-alfa-d-glicopiranosil-d-manitol (1,1-gpm) in vitro, e composição farmacêutica para consumo humano ou animal
MXPA04007183A (es) Composicion farmaceutica para el control de la glucosa en sangre de pacientes con diabetes tipo 2.
DOP2002000451A (es) Nuevas ciclohexilsulfonas (agentes terapéuticos)
BR0214196A (pt) Método e composição para reduzir a atividade de inibir o crescimento de uma célula cancerosa, para tratar de paciente com câncer
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2226 DE 03/09/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 36/064 (2006.01), A61K 31/716 (2006.01), A61K